Stock Price
181.70
Daily Change
3.59 2.02%
Monthly
5.36%
Yearly
-32.79%
Q1 Forecast
177.74

CSL reported $2.87B in Operating Expenses for its fiscal semester ending in June of 2025.





Operating Expenses Change Date
aTyr Pharma USD 26.94M 6.63M Sep/2025
CSL USD 2.87B 2.85B Jun/2025